The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Open accessAbstract
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a major public health problem associated with long-term exposure to toxic gases and particles. We examined the evolution of the pathological effects of airway obstruction in patients with COPD. METHODS: The small airways were assessed in surgically resected lung tissue from 159 patients--39 with stage 0 (at risk), 39 with stage 1, 22 with stage 2, 16 with stage 3, and 43 with stage 4 (very severe) COPD, according to the classification of the Global Initiative for Chronic Obstructive Lung Disease (GOLD). RESULTS: The progression of COPD was strongly associated with an increase in the volume of tissue in the wall (P<0.001) and the accumulation of inflammatory mucous exudates in the lumen (P<0.001) of the small airways. The percentage of the airways that contained polymorphonuclear neutrophils (P<0.001), macrophages (P<0.001), CD4 cells (P=0.02), CD8 cells (P=0.038), B cells (P<0.001), and lymphoid aggregates containing follicles (P=0.003) and the absolute volume of B cells (P=0.03) and CD8 cells (P=0.02) also increased as COPD progressed. CONCLUSIONS: Progression of COPD is associated with the accumulation of inflammatory mucous exudates in the lumen and infiltration of the wall by innate and adaptive inflammatory immune cells that form lymphoid follicles. These changes are coupled to a repair or remodeling process that thickens the walls of these airways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Cellular and Molecular Immunology
Abbas, A. K., Lichtman, A. H., & Pillai, S. S. (1994) · Cited by 3,584
Weibel, E. R. (1963) · Springer eBooks · doi:10.1007/978-3-642-87553-3 · Cited by 3,353
An Introduction to Generalized Linear Models.
Chang, P. C., & Dobson, A. J. (1991) · Journal of the American Statistical Association · doi:10.2307/2290548 · Cited by 2,509
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa030287 · Cited by 2,071
Mucus clearance as a primary innate defense mechanism for mammalian airways
Knowles, M. R., & Boucher, R. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215217 · Cited by 1,054
Site and Nature of Airway Obstruction in Chronic Obstructive Lung Disease
Hogg, J. C., Macklem, P. T., & Thurlbeck, W. M. (1968) · New England Journal of Medicine · doi:10.1056/nejm196806202782501 · Cited by 1,054
Self-citationBiostatistics: A Methodology for the Health Sciences.
D'Agostino, R. B., Fisher, L. D., & van Belle, G. (1995) · Journal of the American Statistical Association · doi:10.2307/2291095 · Cited by 957
Significance of the relationship between lung recoil and maximum expiratory flow.
Mead, J., Turner, J. M., Macklem, P. T., & Little, J. B. (1967) · Journal of Applied Physiology · doi:10.1152/jappl.1967.22.1.95 · Cited by 954
Cited by
Items 101–186 of 186
Lai, H.-C., Lin, T.-L., Chen, T.-W., Kuo, Y.-L., Chang, C.-J., Wu, T.-R., Shu, C.-C., Tsai, Y.-H., Swift, S., & Lu, C.-C. (2022) · Gut · doi:10.1136/gutjnl-2020-322599 · Cited by 331
Patel, B. D., Coxson, H. O., Pillai, S. G., Agustí, A. G. N., Calverley, P. M. A., Donner, C. F., Make, B. J., Müller, N. L., Rennard, S. I., Vestbo, J., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-059oc · Cited by 326
Self-citationCystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure
Henderson, A. G., Ehre, C., Button, B., Abdullah, L. H., Cai, L.-H., Leigh, M. W., DeMaria, G. C., Matsui, H., Donaldson, S. H., Davis, C. W., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73469 · Cited by 326
The three R’s of lung health and disease: repair, remodeling, and regeneration
Beers, M. F., & Morrisey, E. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45961 · Cited by 324
Wasswa-Kintu, S. (2005) · Thorax · doi:10.1136/thx.2004.037135 · Cited by 324
Milara, J., Peiró, T., Serrano, A., & Cortijo, J. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-201761 · Cited by 324
Greene, C. M., Marciniak, S. J., Teckman, J., Ferrarotti, I., Brantly, M. L., Lomas, D. A., Stoller, J. K., & McElvaney, N. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.51 · Cited by 324
The Chronic Bronchitic Phenotype of COPD
Kim, V., Han, M. K., Vance, G. B., Make, B. J., Newell, J. D., Hokanson, J. E., Hersh, C. P., Stinson, D., Silverman, E. K., & Criner, G. J. (2011) · Chest · doi:10.1378/chest.10-2948 · Cited by 323
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers
Willemse, B. W. M., ten Hacken, N. H. T., Rutgers, B., Lesman-Leegte, I. G. A. T., Postma, D. S., & Timens, W. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00108904 · Cited by 322
The roles of tertiary lymphoid structures in chronic diseases
Sato, Y., Silina, K., van den Broek, M., Hirahara, K., & Yanagita, M. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00706-z · Cited by 320
Hatzelmann, A., Morcillo, E. J., Lungarella, G., Adnot, S., Sanjar, S., Beume, R., Schudt, C., & Tenor, H. (2010) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2010.03.011 · Cited by 320
Mechanisms of cigarette smoke-induced COPD: insights from animal models
Churg, A., Cosio, M., & Wright, J. L. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00390.2007 · Cited by 319
Role of HDAC2 in the Pathophysiology of COPD
Barnes, P. J. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163257 · Cited by 318
Time course of cigarette smoke-induced pulmonary inflammation in mice
D'hulst, A. I., Vermaelen, K. Y., Brusselle, G. G., Joos, G. F., & Pauwels, R. A. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00095204 · Cited by 317
Tunney, M. M., Einarsson, G. G., Wei, L., Drain, M., Klem, E. R., Cardwell, C., Ennis, M., Boucher, R. C., Wolfgang, M. C., & Elborn, J. S. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201210-1937oc · Cited by 316
Brightling, C. E., Bleecker, E. R., Panettieri, R. A., Bafadhel, M., She, D., Ward, C. K., Xu, X., Birrell, C., & van der Merwe, R. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70187-0 · Cited by 315
Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma
Boivin, W. A., Cooper, D. M., Hiebert, P. R., & Granville, D. J. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.91 · Cited by 314
Kardos, P., Wencker, M., Glaab, T., & Vogelmeier, C. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-244oc · Cited by 314
Cigarette Smoke–induced Emphysema: A Role for the B Cell?
van der Strate, B. W. A., Postma, D. S., Brandsma, C.-A., Melgert, B. N., Luinge, M. A., Geerlings, M., Hylkema, M. N., van den Berg, A., Timens, W., & Kerstjens, H. A. M. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200504-594oc · Cited by 311
Pulmonary Lymphoid Neogenesis in Idiopathic Pulmonary Arterial Hypertension
Perros, F., Dorfmüller, P., Montani, D., Hammad, H., Waelput, W., Girerd, B., Raymond, N., Mercier, O., Mussot, S., Cohen-Kaminsky, S., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0927oc · Cited by 308
Matrix metalloproteinases in COPD
Churg, A., Zhou, S., & Wright, J. L. (2012) · European Respiratory Journal · doi:10.1183/09031936.00121611 · Cited by 308
Cigarette smoke induces cellular senescence
Nyunoya, T., Monick, M. M., Klingelhutz, A., Yarovinsky, T. O., Cagley, J. R., & Hunninghake, G. W. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0169oc · Cited by 306
Young, R. P., Hopkins, R., & Eaton, T. E. (2007) · European Respiratory Journal · doi:10.1183/09031936.00021707 · Cited by 306
Progress in the mechanism and targeted drug therapy for COPD
Wang, C., Zhou, J., Wang, J., Li, S., Fukunaga, A., Yodoi, J., & Tian, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00345-x · Cited by 303
Pathogenic triad in COPD: oxidative stress, protease–antiprotease imbalance, and inflammation
Fischer, B., Pavlisko, E., & Voynow, J. (2011) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s10770 · Cited by 301
Corticosteroids: The drugs to beat
Barnes, P. J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.052 · Cited by 301
The IL-1 cytokine family and its role in inflammation and fibrosis in the lung
Borthwick, L. A. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0559-z · Cited by 294
Zarogoulidis, P., Papanas, N., Kioumis, I., Chatzaki, E., Maltezos, E., & Zarogoulidis, K. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1161-x · Cited by 299
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients
de Torres, J. P., Cordoba-Lanus, E., López-Aguilar, C., Muros de Fuentes, M., Montejo de Garcini, A., Aguirre-Jaime, A., Celli, B. R., & Casanova, C. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00109605 · Cited by 297
Koo, H.-K., Vasilescu, D. M., Booth, S., Hsieh, A., Katsamenis, O. L., Fishbane, N., Elliott, W. M., Kirby, M., Lackie, P., Sinclair, I., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30196-6 · Cited by 296
Self-citationChronic obstructive pulmonary disease and comorbidities
Decramer, M., & Janssens, W. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(12)70060-7 · Cited by 291
The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases
Lee, J.-W., Chun, W., Lee, H. J., Min, J.-H., Kim, S.-M., Seo, J.-Y., Ahn, K.-S., & Oh, S.-R. (2021) · Cells · doi:10.3390/cells10040897 · Cited by 291
Wiegman, C. H., Li, F., Ryffel, B., Togbe, D., & Chung, K. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01957 · Cited by 288
DePianto, D. J., Chandriani, S., Abbas, A. R., Jia, G., N'Diaye, E. N., Caplazi, P., Kauder, S. E., Biswas, S., Karnik, S. K., Ha, C., et al. (2015) · Thorax · doi:10.1136/thoraxjnl-2013-204596 · Cited by 287
Airway Mucus: From Production to Secretion
Williams, O. W., Sharafkhaneh, A., Kim, V., Dickey, B. F., & Evans, C. M. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0436sf · Cited by 284
Vermaelen, K., & Pauwels, R. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1384so · Cited by 283
COPD: the dangerous underestimate of 15%
Rennard, S. I., & Vestbo, J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68516-4 · Cited by 278
Techniques of assessing small airways dysfunction
McNulty, W., & Usmani, O. S. (2014) · European Clinical Respiratory Journal · doi:10.3402/ecrj.v1.25898 · Cited by 275
Ectopic lymphoid tissues and local immunity
Carragher, D. M., Rangel-Moreno, J., & Randall, T. D. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.12.004 · Cited by 274
Coxson, H. O., Dirksen, A., Edwards, L. D., Yates, J. C., Agusti, A., Bakke, P., Calverley, P. M., Celli, B., Crim, C., Duvoix, A., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70006-7 · Cited by 274
Self-citationNCR+ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures
Carrega, P., Loiacono, F., Di Carlo, E., Scaramuccia, A., Mora, M., Conte, R., Benelli, R., Spaggiari, G. M., Cantoni, C., Campana, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms9280 · Cited by 271
Tissue-specific Role of CX3CR1 Expressing Immune Cells and Their Relationships with Human Disease
Lee, M., Lee, Y., Song, J., Lee, J., & Chang, S.-Y. (2018) · Immune Network · doi:10.4110/in.2018.18.e5 · Cited by 260
“CX3CL1/CX3CR1 interaction plays an important role in the pathophysiology of chronic obstructive pulmonary disease (COPD), a chronic disease in which mucus exudates accumulate in a narrow airway with destruction of lung parenchymal cells, resulting in enlargement of airspace (57).”
BackgroundAbnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
Faner, R., Rojas, M., MacNee, W., & Agustí, A. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201202-0282pp · Cited by 268
King, P. T. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0068-z · Cited by 269
Autoantibodies in Patients with Chronic Obstructive Pulmonary Disease
Feghali-Bostwick, C. A., Gadgil, A. S., Otterbein, L. E., Pilewski, J. M., Stoner, M. W., Csizmadia, E., Zhang, Y., Sciurba, F. C., & Duncan, S. R. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-014oc · Cited by 269
Self-citationSchmidt, M., Dekker, F. J., & Maarsingh, H. (2013) · Pharmacological Reviews · doi:10.1124/pr.110.003707 · Cited by 267
Agustí, A. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200701-004fm · Cited by 265
The natural history of chronic obstructive pulmonary disease
Mannino, D. M., Watt, G., Hole, D., Gillis, C., Hart, C., McConnachie, A., Davey Smith, G., Upton, M., Hawthorne, V., Sin, D. D., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00024605 · Cited by 265
Molecular pathogenesis of emphysema
Taraseviciene-Stewart, L., & Voelkel, N. F. (2008) · Journal of Clinical Investigation · doi:10.1172/jci31811 · Cited by 263
Mechanisms of airway epithelial injury and abnormal repair in asthma and COPD
Raby, K. L., Michaeloudes, C., Tonkin, J., Chung, K. F., & Bhavsar, P. K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1201658 · Cited by 260
COPD: current therapeutic interventions and future approaches
Barnes, P. J., & Stockley, R. A. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00139104 · Cited by 259
Trian, T., Benard, G., Begueret, H., Rossignol, R., Girodet, P.-O., Ghosh, D., Ousova, O., Vernejoux, J.-M., Marthan, R., Tunon-de-Lara, J.-M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070956 · Cited by 258
Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients
Araya, J., Cambier, S., Markovics, J. A., Wolters, P., Jablons, D., Hill, A., Finkbeiner, W., Jones, K., Broaddus, V. C., Sheppard, D., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32526 · Cited by 257
Chronic Obstructive Pulmonary Disease and Lung Cancer: New Molecular Insights
Adcock, I. M., Caramori, G., & Barnes, P. J. (2011) · Respiration · doi:10.1159/000324601 · Cited by 257
Mitochondrial iron chelation ameliorates cigarette smoke–induced bronchitis and emphysema in mice
Cloonan, S. M., Glass, K., Laucho-Contreras, M. E., Bhashyam, A. R., Cervo, M., Pabón, M. A., Konrad, C., Polverino, F., Siempos, I. I., Perez, E., et al. (2016) · Nature Medicine · doi:10.1038/nm.4021 · Cited by 257
Overview of the Mechanisms of Oxidative Stress: Impact in Inflammation of the Airway Diseases
Albano, G. D., Gagliardo, R. P., Montalbano, A. M., & Profita, M. (2022) · Antioxidants · doi:10.3390/antiox11112237 · Cited by 256
Bronchus-Associated Lymphoid Tissue (BALT)
Randall, T. D. (2010) · Advances in Immunology · doi:10.1016/b978-0-12-381300-8.00007-1 · Cited by 255
Demedts, I. K., Bracke, K. R., Van Pottelberge, G., Testelmans, D., Verleden, G. M., Vermassen, F. E., Joos, G. F., & Brusselle, G. G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200608-1113oc · Cited by 254
Cigarette Smoke-Induced Pulmonary Inflammation and Emphysema Are Attenuated in CCR6-Deficient Mice
Bracke, K. R., D’hulst, A. I., Maes, T., Moerloose, K. B., Demedts, I. K., Lebecque, S., Joos, G. F., & Brusselle, G. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4350 · Cited by 254
Host Response to the Lung Microbiome in Chronic Obstructive Pulmonary Disease
Sze, M. A., Dimitriu, P. A., Suzuki, M., McDonough, J. E., Campbell, J. D., Brothers, J. F., Erb-Downward, J. R., Huffnagle, G. B., Hayashi, S., Elliott, W. M., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201502-0223oc · Cited by 254
Self-citationAntiinflammatory Effects of Salmeterol/Fluticasone Propionate in Chronic Obstructive Lung Disease
Barnes, N. C., Qiu, Y.-S., Pavord, I. D., Parker, D., Davis, P. A., Zhu, J., Johnson, M., Thomson, N. C., & Jeffery, P. K. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200508-1321oc · Cited by 253
Pulmonary characteristics in COPD and mechanisms of increased work of breathing
Loring, S. H., Garcia-Jacques, M., & Malhotra, A. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00008.2009 · Cited by 246
Exhaled Particles and Small Airways
Bake, B., Larsson, P., Ljungkvist, G., Ljungström, E., & Olin, A.-C. (2019) · Respiratory Research · doi:10.1186/s12931-019-0970-9 · Cited by 218
Lung ageing and COPD: is there a role for ageing in abnormal tissue repair?
Brandsma, C.-A., de Vries, M., Costa, R., Woldhuis, R. R., Königshoff, M., & Timens, W. (2017) · European Respiratory Review · doi:10.1183/16000617.0073-2017 · Cited by 221
CXCR2 antagonists for the treatment of pulmonary disease
Chapman, R. W., Phillips, J. E., Hipkin, R. W., Curran, A. K., Lundell, D., & Fine, J. S. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.005 · Cited by 214
Pathogenesis of prion diseases: current status and future outlook
Aguzzi, A., & Heikenwalder, M. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1492 · Cited by 207
Exhaled nitric oxide from lung periphery is increased in COPD
Brindicci, C., Ito, K., Resta, O., Pride, N. B., Barnes, P. J., & Kharitonov, S. A. (2005) · European Respiratory Journal · doi:10.1183/09031936.04.00125304 · Cited by 206
Kitamura, H., Cambier, S., Somanath, S., Barker, T., Minagawa, S., Markovics, J., Goodsell, A., Publicover, J., Reichardt, L., Jablons, D., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45589 · Cited by 189
Piet, B., de Bree, G. J., Smids-Dierdorp, B. S., van der Loos, C. M., Remmerswaal, E. B. M., von der Thüsen, J. H., van Haarst, J. M. W., Eerenberg, J. P., ten Brinke, A., van der Bij, W., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44675 · Cited by 183
Microbiota Promotes Chronic Pulmonary Inflammation by Enhancing IL-17A and Autoantibodies
Yadava, K., Pattaroni, C., Sichelstiel, A. K., Trompette, A., Gollwitzer, E. S., Salami, O., von Garnier, C., Nicod, L. P., & Marsland, B. J. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0779oc · Cited by 184
Pathogenesis of hyperinflation in chronic obstructive pulmonary disease
Saey, Gagnon, P., Guenette, J., Langer, D., Laviolette, L., Mainguy, V., Maltais, F., & Ribeiro, F. (2014) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s38934 · Cited by 204
“In early COPD, the forced expiratory volume in one second (FEV 1 ) may not be the optimal indicator of small airways obstruction.”
InfluentialComputed tomographic imaging of the airways: relationship to structure and function
de Jong, P. A., Müller, N. L., Paré, P. D., & Coxson, H. O. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00007105 · Cited by 171
Self-citationChanges in elastic fibres in the small airways and alveoli in COPD
Black, P. N., Ching, P. S. T., Beaumont, B., Ranasinghe, S., Taylor, G., & Merrilees, M. J. (2008) · European Respiratory Journal · doi:10.1183/09031936.00017207 · Cited by 151
Campbell, J. D., McDonough, J. E., Zeskind, J. E., Hackett, T. L., Pechkovsky, D. V., Brandsma, C.-A., Suzuki, M., Gosselink, J. V., Liu, G., Alekseyev, Y. O., et al. (2012) · Genome Medicine · doi:10.1186/gm367 · Cited by 128
Self-citationDoes the Respiratory System Limit Exercise in Mild Chronic Obstructive Pulmonary Disease?
Chin, R. C., Guenette, J. A., Cheng, S., Raghavan, N., Amornputtisathaporn, N., Cortés-Télles, A., Webb, K. A., & O’Donnell, D. E. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201211-1970oc · Cited by 123
Sharma, G., Hanania, N. A., & Shim, Y. M. (2009) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200904-022rm · Cited by 105
Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD
O'Donnell, D. E., Laveneziana, P., Ora, J., Webb, K. A., Lam, Y.-M., & Ofir, D. (2009) · Thorax · doi:10.1136/thx.2008.103598 · Cited by 104
Alterations in lung mast cell populations in patients with chronic obstructive pulmonary disease
Andersson, C. K., Mori, M., Bjermer, L., Löfdahl, C.-G., & Erjefält, J. S. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0932oc · Cited by 101
Selective Targeting of TGF-β Activation to Treat Fibroinflammatory Airway Disease
Minagawa, S., Lou, J., Seed, R. I., Cormier, A., Wu, S., Cheng, Y., Murray, L., Tsui, P., Connor, J., Herbst, R., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008074 · Cited by 90
Physiologic Basis for Improved Pulmonary Function after Lung Volume Reduction
Fessler, H. E., Scharf, S. M., Ingenito, E. P., McKenna, R. J., & Sharafkhaneh, A. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200708-117et · Cited by 84
Healy, C., Munoz-Wolf, N., Strydom, J., Faherty, L., Williams, N. C., Kenny, S., Donnelly, S. C., & Cloonan, S. M. (2021) · Respiratory Research · doi:10.1186/s12931-021-01722-y · Cited by 78
Turan, N., Kalko, S., Stincone, A., Clarke, K., Sabah, A., Howlett, K., Curnow, S. J., Rodriguez, D. A., Cascante, M., O'Neill, L., et al. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002129 · Cited by 74
Experimental evidence of age-related adaptive changes in human acinar airways
Quirk, J. D., Sukstanskii, A. L., Woods, J. C., Lutey, B. A., Conradi, M. S., Gierada, D. S., Yusen, R. D., Castro, M., & Yablonskiy, D. A. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00541.2015 · Cited by 51
The origin and role of innate lymphoid cells in the lung
Lai, D.-M., Shu, Q., & Fan, J. (2016) · Military Medical Research · doi:10.1186/s40779-016-0093-2 · Cited by 45
Sin, D. D., & Man, S. F. P. (2008) · Chest · doi:10.1378/chest.07-2085 · Cited by 25
Lung imaging in COPD and asthma
Tanabe, N., Nakagawa, H., Sakao, S., Ohno, Y., Shimizu, K., Nakamura, H., Hanaoka, M., Nakano, Y., & Hirai, T. (2024) · Respiratory Investigation · doi:10.1016/j.resinv.2024.08.014 · Cited by 21
Metadata
- Authors
- Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., & Paré, P. D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-06-24
- Volume
- 350
- Issue
- 26
- Pages
- 2645-2653
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2145466675
- Cited by
- 3,782
- References
- 38
- FWCI
- 120.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.